These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19551812)

  • 1. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity.
    Gentry PR; McDonald TB; Sullivan DE; Shipp AM; Yager JW; Clewell HJ
    Environ Mol Mutagen; 2010 Jan; 51(1):1-14. PubMed ID: 19551812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
    Soto A; DelRaso NJ; Schlager JJ; Chan VT
    Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
    Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
    BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals.
    Islaih M; Halstead BW; Kadura IA; Li B; Reid-Hubbard JL; Flick L; Altizer JL; Thom Deahl J; Monteith DK; Newton RK; Watson DE
    Mutat Res; 2005 Oct; 578(1-2):100-16. PubMed ID: 16109433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
    Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
    Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of gene expression profiles in TK6 human cells exposed to DNA-oxidizing agents.
    Platel A; Gervais V; Sajot N; Nesslany F; Marzin D; Claude N
    Mutat Res; 2010 Jul; 689(1-2):21-49. PubMed ID: 20466008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.
    Chilakapati J; Wallace K; Ren H; Fricke M; Bailey K; Ward W; Creed J; Kitchin K
    Toxicology; 2010 Jan; 268(1-2):31-9. PubMed ID: 19945496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
    Mudipalli A; Owen RD; Preston RJ
    Int J Oncol; 2005 Sep; 27(3):769-78. PubMed ID: 16077927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer.
    Sen B; Wolf DC; Turpaz Y; Bugrim A; Retief J; Hester SD
    Toxicol In Vitro; 2007 Dec; 21(8):1513-29. PubMed ID: 17720352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
    Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
    Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2).
    Tchounwou PB; Yedjou CG; Dorsey WC
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1071-9. PubMed ID: 14682389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.